Toll Free: 1-888-928-9744

Global Active Pharmaceutical Ingredient (API) Market Professional Survey Report 2016

Published: May 24, 2016 | Pages: 164 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report
Mainly covers the following product types
    Chemical synthetic drugs
    Natural medicine chemistry
The segment applications including
    Hospital use
    Clinic
    Household
    School
    Others
Segment regions including (the separated region report can also be offered)
    USA
    China
    UK
    France
    Switzerland
    Japan
    Germany
    India
The players list (Partly, Players you are interested in can also be added)
    Dr Reddy's Laboratories
    Cipla
    Ranbaxy Laboratories
    Zhejiang Hisun Pharmaceutical Co. Ltd.
    Fabbrica Italiana Sintetici
    Cambrex Corporation
    Pfizer CentreSource
    Teva Active Pharmaceutical Ingredients
    Lonza
    Daiichi Fine Chemical
    Sun Pharma
    Ranbaxy
    Sandoz
    Cipla
    Aurobindo
    TAPI
    Dr. Reddy's Laboratories Ltd
    Mylan
With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Box and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Box, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!


 Table of Contents
1 Industry Overview of Active Pharmaceutical Ingredient (API) 1.1 Definition and Specifications of Active Pharmaceutical Ingredient (API) 1.1.1 Definition of Active Pharmaceutical Ingredient (API) 1.1.2 Specifications of Active Pharmaceutical Ingredient (API) 1.2 Classification of Active Pharmaceutical Ingredient (API) 1.2.1 Chemical synthetic drugs 1.2.2 Natural medicine chemistry 1.3 Applications of Active Pharmaceutical Ingredient (API) 1.3.1 Hospital use 1.3.2 Clinic 1.3.3 Household 1.3.4 School 1.3.5 Others 1.4 Industry Chain Structure of Active Pharmaceutical Ingredient (API) 1.5 Industry Overview and Major Regions Status of Active Pharmaceutical Ingredient (API) 1.5.1 Industry Overview of Active Pharmaceutical Ingredient (API) 1.5.2 Global Major Regions Status of Active Pharmaceutical Ingredient (API) 1.6 Industry Policy Analysis of Active Pharmaceutical Ingredient (API) 1.7 Industry News Analysis of Active Pharmaceutical Ingredient (API) 2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient (API) 2.1 Raw Material Suppliers and Price Analysis of Active Pharmaceutical Ingredient (API) 2.2 Equipment Suppliers and Price Analysis of Active Pharmaceutical Ingredient (API) 2.3 Labor Cost Analysis of Active Pharmaceutical Ingredient (API) 2.4 Other Costs Analysis of Active Pharmaceutical Ingredient (API) 2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient (API) 2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredient (API) 3 Technical Data and Manufacturing Plants Analysis of Active Pharmaceutical Ingredient (API) 3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2015 3.3 R&D Status and Technology Source of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient (API) Major Manufacturers in 2015 4 Global Active Pharmaceutical Ingredient (API) Overall Market Overview 4.1 2011-2016E Overall Market Analysis 4.2.1 2011-2015 Global Active Pharmaceutical Ingredient (API) Capacity and Growth Rate Analysis 4.2.2 2015 Active Pharmaceutical Ingredient (API) Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2011-2015 Global Active Pharmaceutical Ingredient (API) Sales and Growth Rate Analysis 4.3.2 2015 Active Pharmaceutical Ingredient (API) Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2011-2015 Global Active Pharmaceutical Ingredient (API) Sales Price 4.4.2 2015 Active Pharmaceutical Ingredient (API) Sales Price Analysis (Company Segment) 4.5 Gross Margin Analysis 4.5.1 2011-2015 Global Active Pharmaceutical Ingredient (API) Gross Margin 4.5.2 2015 Active Pharmaceutical Ingredient (API) Gross Margin Analysis (Company Segment) 5 Active Pharmaceutical Ingredient (API) Regional Market Analysis 5.1 USA Active Pharmaceutical Ingredient (API) Market Analysis 5.1.1 USA Active Pharmaceutical Ingredient (API) Market Overview 5.1.2 USA 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.1.3 USA 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.1.4 USA 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.2 China Active Pharmaceutical Ingredient (API) Market Analysis 5.2.1 China Active Pharmaceutical Ingredient (API) Market Overview 5.2.2 China 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.2.3 China 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.2.4 China 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.3 UK Active Pharmaceutical Ingredient (API) Market Analysis 5.3.1 UK Active Pharmaceutical Ingredient (API) Market Overview 5.3.2 UK 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.3.3 UK 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.3.4 UK 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.4 France Active Pharmaceutical Ingredient (API) Market Analysis 5.4.1 France Active Pharmaceutical Ingredient (API) Market Overview 5.4.2 France 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.4.3 France 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.4.4 France 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.5 Switzerland Active Pharmaceutical Ingredient (API) Market Analysis 5.5.1 Switzerland Active Pharmaceutical Ingredient (API) Market Overview 5.5.2 Switzerland 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Switzerland 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.5.4 Switzerland 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.6 Japan Active Pharmaceutical Ingredient (API) Market Analysis 5.6.1 Japan Active Pharmaceutical Ingredient (API) Market Overview 5.6.2 Japan 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.6.3 Japan 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.6.4 Japan 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.7 Germany Active Pharmaceutical Ingredient (API) Market Analysis 5.7.1 Germany Active Pharmaceutical Ingredient (API) Market Overview 5.7.2 Germany 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.7.3 Germany 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.7.4 Germany 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 5.8 India Active Pharmaceutical Ingredient (API) Market Analysis 5.8.1 India Active Pharmaceutical Ingredient (API) Market Overview 5.8.2 India 2011-2016E Active Pharmaceutical Ingredient (API) Local Supply, Import, Export, Local Consumption Analysis 5.8.3 India 2011-2016E Active Pharmaceutical Ingredient (API) Sales Price Analysis 5.8.4 India 2015 Active Pharmaceutical Ingredient (API) Market Share Analysis 6 Global 2011-2016E Active Pharmaceutical Ingredient (API) Segment Market Analysis (by Type) 6.1 Global 2011-2016E Active Pharmaceutical Ingredient (API) Sales by Type 6.2 Different Types Active Pharmaceutical Ingredient (API) Product Interview Price Analysis 6.3 Different Types Active Pharmaceutical Ingredient (API) Product Driving Factors Analysis 6.3.1 Chemical synthetic drugs Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 6.3.2 Natural medicine chemistry Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 7 Global 2011-2016E Active Pharmaceutical Ingredient (API) Segment Market Analysis (by Application) 7.1 Global 2011-2016E Consumption by Application 7.2 Different Application Product Interview Price Analysis 7.3 Different Application Product Driving Factors Analysis 7.3.1 Hospital use Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 7.3.2 Clinic Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 7.3.3 Household Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 7.3.4 School Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 7.3.5 Others Active Pharmaceutical Ingredient (API) Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Active Pharmaceutical Ingredient (API) 8.1 Dr Reddy's Laboratories 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.3 Dr Reddy's Laboratories 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Dr Reddy's Laboratories 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.2 Cipla 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.3 Cipla 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Cipla 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.3 Ranbaxy Laboratories 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.3 Ranbaxy Laboratories 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Ranbaxy Laboratories 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.4 Zhejiang Hisun Pharmaceutical Co. Ltd. 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.3 Zhejiang Hisun Pharmaceutical Co. Ltd. 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Zhejiang Hisun Pharmaceutical Co. Ltd. 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.5 Fabbrica Italiana Sintetici 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.3 Fabbrica Italiana Sintetici 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Fabbrica Italiana Sintetici 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.6 Cambrex Corporation 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.3 Cambrex Corporation 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Cambrex Corporation 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.7 Pfizer CentreSource 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.3 Pfizer CentreSource 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Pfizer CentreSource 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.8 Teva Active Pharmaceutical Ingredients 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.3 Teva Active Pharmaceutical Ingredients 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Teva Active Pharmaceutical Ingredients 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.9 Lonza 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.3 Lonza 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Lonza 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.10 Daiichi Fine Chemical 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.3 Daiichi Fine Chemical 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Daiichi Fine Chemical 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.11 Sun Pharma 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.3 Sun Pharma 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 Sun Pharma 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.12 Ranbaxy 8.12.1 Company Profile 8.12.2 Product Picture and Specifications 8.12.3 Ranbaxy 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.12.4 Ranbaxy 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.13 Sandoz 8.13.1 Company Profile 8.13.2 Product Picture and Specifications 8.13.3 Sandoz 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.13.4 Sandoz 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.14 Cipla 8.14.1 Company Profile 8.14.2 Product Picture and Specifications 8.14.3 Cipla 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.14.4 Cipla 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.15 Aurobindo 8.15.1 Company Profile 8.15.2 Product Picture and Specifications 8.15.3 Aurobindo 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.15.4 Aurobindo 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.16 TAPI 8.16.1 Company Profile 8.16.2 Product Picture and Specifications 8.16.3 TAPI 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.16.4 TAPI 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.17 Dr. Reddy's Laboratories Ltd 8.17.1 Company Profile 8.17.2 Product Picture and Specifications 8.17.3 Dr. Reddy's Laboratories Ltd 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.17.4 Dr. Reddy's Laboratories Ltd 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 8.18 Mylan 8.18.1 Company Profile 8.18.2 Product Picture and Specifications 8.18.3 Mylan 2015 Active Pharmaceutical Ingredient (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.18.4 Mylan 2015 Active Pharmaceutical Ingredient (API) Business Region Distribution Analysis 9 Development Trend of Analysis of Market 9.1 Global Market Trend Analysis 9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast 9.1.2 Global 2016-2021 Sales Price Forecast 9.1.3 Global 2016-2021 Gross Margin Forecast 9.2 Regional Market Trend 9.2.1 USA 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.2 China 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.3 UK 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.4 France 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.5 Switzerland 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.6 Japan 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.7 Germany 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.2.8 India 2016-2021 Active Pharmaceutical Ingredient (API) Consumption Forecast 9.3 Market Trend (Product type) 9.4 Market Trend (Application) 10 Active Pharmaceutical Ingredient (API) Marketing Model Analysis 10.1 Active Pharmaceutical Ingredient (API) Regional Marketing Model Analysis 10.2 Active Pharmaceutical Ingredient (API) International Trade Model Analysis 10.3 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredient (API) by Regions 10.4 Active Pharmaceutical Ingredient (API) Supply Chain Analysis 11 Consumers Analysis of Active Pharmaceutical Ingredient (API) 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis … 12 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient (API) 12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredient (API) 12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient (API) 13 Conclusion of the Global Active Pharmaceutical Ingredient (API) Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...
Choose License Type
Single User - US $3500
Multi User - US $7000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify